# Liraglutide Efficacy on Glucocorticoid Induced Hyperglycemia in Patients High Risk for Diabetes

> **NCT02016846** · PHASE3 · UNKNOWN · sponsor: **Rabin Medical Center** · enrollment: 36 (estimated)

## Conditions studied

- Glucocorticoid Induced Hyperglycemia

## Interventions

- **DRUG:** Liraglutide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02016846
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2015-01
- **Final completion:** —
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2013-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02016846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02016846, "Liraglutide Efficacy on Glucocorticoid Induced Hyperglycemia in Patients High Risk for Diabetes". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02016846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*